Media & Resources

New Indian Medicinal Chemistry Programme towards Advancement of Novel Neutralizing Antibody Approach (NEW DELHI AND NEW YORK – May 2, 2007) — The Department of Biotechnology, Ministry of Science & Technology, Government of India and the International AIDS Vaccine Initiative signed an agreement today to address a major obstacle in AIDS vaccine development: the design…

IAVI Ranks among Top One Percent of Charities Nationwide NEW YORK, March 27, 2007 — For the sixth consecutive year, the International AIDS Vaccine Initiative (IAVI) has been awarded the highest rating of four stars by Charity Navigator, a leading independent charity evaluator. This rating, based upon IAVI’s strong commitment to programmatic work, places the…

The International AIDS Vaccine Initiative (IAVI) mourns the loss of Dr. Kenneth Anthony Kalanyi Kebba, a partner and colleague with the Medical Research Council (MRC) and the Uganda Virus Research Institute (UVRI) in Uganda, and a brilliant young scientist who played a large role as a clinical investigator for the first HIV vaccine trial undertaken…

The International AIDS Vaccine Initiative (IAVI) issued this statement on February 20, 2007 following an announcement made by the Canadian government and the Bill & Melinda Gates Foundation to pledge up to CAD$139 million for the creation of a Canadian HIV Vaccine Initiative (CHVI). The new CHVI will contribute to the global effort to develop…

“Vaccines for the Future Act of 2007” Calls for Financial Support for Advance Market Commitments The International AIDS Vaccine Initiative (IAVI) applauds Senator Richard Lugar (R-Indiana) for his leadership in introducing “Vaccines for the Future Act of 2007” legislation. His proposal calls for a comprehensive strategy to speed the development, testing and distribution of vaccines…

he International AIDS Vaccine Initiative (IAVI) applauds the governments of Canada, Italy, Norway, Russia and the United Kingdom, as well as the Bill & Melinda Gates Foundation for their leadership and generosity in establishing a pilot Advance Market Commitment (AMC) program, an innovative financing mechanism aimed at accelerating the research, development and production of new…

The International AIDS Vaccine Initiative (IAVI) mourns the tragic death of our friend and colleague, Professor Job Joab Bwayo, co-founder and director of the Kenya AIDS Vaccine Initiative (KAVI) in Nairobi, Kenya. Prof. Bwayo, a passionate AIDS advocate, dedicated much of his distinguished career to developing an HIV vaccine for communities throughout the African continent.…

IAVI Issues Annual Map of AIDS Vaccine Research Activity Worldwide NEW YORK, January 31, 2007 — The International AIDS Vaccine Initiative’s (IAVI) January 2007 Annual Issue of VAX, an editorially independent bulletin on AIDS vaccine research published by IAVI, reports that 13 new preventive AIDS vaccine trials were initiated in eight countries around the world…